Hello all , I’m an intern and here is a case history of  one of our patients who got admitted .
This is to complete my log book as a part of my internship duty.

11/04/2020
A 47 year old female presented to OPD with complaints of
Difficulty in breathing since 10 days not aggravated or relieved with positional or diurnal variation
palpitations since 10 days  which were short lasting
Bilateral pitting type of edema of lower extremities  since 10 days
No h/o pain or warmth at the local sites of edema , no color change
No h/o facial puffiness or abdominal distention.

She is a known hypertensive pt since 20 years .
she is on medication tab . Telmisartan 20mg daily

H/o filariasis in rt lower limb since 15 years and is using medication DEC 100 mg for 2 weeks in a year.

 On general EXAMINATION
 Pt was c/c
Temperature:96.5 F
Bp:130/90mm Hg
Pulse:84 bpm
Spo2: 99%

CVS: S1 S2 heard

RESPIRATORY SYSTEM: b/l normal vesicular breath sounds
P/A: shape of the abdomen: obese
        No free fluid ,scars ,sinuses
        Hernial orifices normal
         No tenderness
          Liver is palpable 2-3 cms
         Spleen is palpable- 4 cms
          Bowel sounds present

 CNS: HMF intact
           Speech normal
           Sensory system normal
            Motor system normal
   
INVESTIGATIONS
 Hemogram:    On presentation she had hb-4.5 gm/dl .
After
1 st blood transfusion On12/05/20 hb:6.2 gm/dl
                    Total count:14,200 cells/cumm
                     Pcv:18.3 vol
                      Rbc:1.96 millions/cumm
                     Platelet: 1.01 lakhs/cumm
After 2 ndblood tranfusion
    On 15/05/20 hb: 9gm/dl
                      Pcv:28.6 vol%
                       Mchc:31.3%
                       Rdw-cv 19.5%
Serum iron- 40ug/dl
Serum ferritin- 109ng/ml

 Rft: urea- 10mg/dl
        Sodium-139mEq/l
         Potassium-4.1mEq/l
         Chloride-104mEq/l

Lft:Total bilirubin-1.28mg/dl
       Direct bilirubin-0.52mg/dl
        SGOT-24IU/L
         SGPT-12IU/L
         Alkaline phosphate- 118IU/L
         Total proteins - 5.7gm/dl
          Albumin-3.7gm/dl

Blood smear picture :

 
RBC:hypochromic with anisopoikilocytosis comprising normocytes ,macrocytes ,tear drop cells,schistocytes, ,polychromasia and nucleated rbcs 2-3 / 100 wbc
WBC: normal count with hypersegmented neutrophils and mild shift to left
Platelets: adequate
No parasites
Impression: normocytic hypochromic anemia with hypersegmented neutrophils
             -? Megaloblastic anemia
              -? Hemolytic anemia

Osmotic fragility-lysis starts at 0.45%
                              Completes at 0.33%
Stool culture: no pus cells,no rbcs, no parasitic forms of ova / cyst seen

Stool for occult blood: positive

Serology is negative

Direct coombs test negative
Indirect coombs test POSITIVE

USG abdomen-splenomegaly
                          Fibroid uterus
                          Right hydrosalpinx
2d echo: mild dilated R.A/ R.V

PROCEDURE LEARNT: BONE MARROW ASPIRATION ( site- sternum) done on 13/05/20

First consent was taken from the patient for the procedure and the pt didn’t agree for video recording of the procedure. Then the patient was given a test dose of xylocaine. After half and hour at the level of 2 nd intercoastal space 10ml xylocaine was given then marrow was Aspirated.


  Report: reactive marrow with erythroid hyperplasia
 
DIAGNOSIS:
      ?megaloblastic anemia
       ?hemolytic anemia

TREATMENT GIVEN:

Planned for 2 prbc blood transfusion
Inj. Vitcofol 2cc/im/od (D 3/5)
T.livogen  150mg/po/od for 1 month
T.MVT/po/od
Inj methylcobalamine  1 amp/im/od 500 mcg for 5 days (D1/5)

ADVICE AT DISCHARGE:
Inj. Hydroxocobalamin 1000 mcg for 3 days. Followed with weekly once for 1 month. Later on monthly once for 2 months
T. MVT po od for 1

Topic learnt today : myelodysplastic syndrome

(MDS)Myelodysplastic syndrome is a clonal hematopoietic stem cell disorder characterised by morphological dysplastic changes in one or more of major hematopoietic cell lines.
MDS can be presented with cytopenias - neutropenia, anemia and thrombocytopenia.

FAB classification was recommended early and as modified by WHO .
WHO uses percentage of blasts in bone marrow, ring sideroblasts and dysplastic changes to differentiate MDS subtypes.
1. Refractory anemia
2.refractory anemia with ringed sideroblasts
3. Refractory cytopenia with multilineage dysplasia
4. Refractory cytopenia with multilineage dysplasia and ringed sideroblasts
5.refractory anemia with excess blasts
6.myelodysplastic syndrome unclassified
7. MDS with isolated del (5q)

Some of the cytopenic causes are:
A.Chronic liver disease
B.drug induced cytopenia
C.excessive alcohol intake
D.b12/folate deficiency
E.autoimmune cytopenia
F. Anemia of chronic disorders
G . Parasitic infections

Stem cell disorders like IDUS,ICUS ,CCUS,CHIP


Intext source https://www.intechopen.com/books/recent-developments-in-myelodysplastic-syndromes/diagnosis-and-classification-of-myelodysplastic-syndrome

Clinical presentation : infection,bleeding/bruising ,gum bleeding,petechiae
Symptoms include general weakness, pallor,shirtness of breath
On physical examination enlarged spleen size.

Investigations : complete blood picture,serum ferritin, serum iron,stool culture,2d echo,USG abdomen, bone marrow aspiration.

Dysplastic changes include :
Dyserythropoiesis
Dysmyelopoiesis
Dysmegakaryopoiesis

Treatment
Blood transfusion
Chemotherapy
Hormone replacement therapy
Bone marrow transplant



Comments